drugset / Trial / NCT02014532
Role of Leukotriene Receptor Antagonists in Treatment of Chronic Periodontitis
RandomizedParallel-groupTriple-blindTreatment
Summary
The adjunctive use of Leukotriene Receptor Antagonist (Montelukast) along with scaling and root planing in patients with chronic periodontitis leads to host inflammatory response modulation and decrease in serum C reactive protein (CRP) levels. If proven this will open new vistas in treatment of chronic periodontitis.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-07
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Montelukast | Other / unclassified | 10 mg | — |